Get started
ELI LILLY AND COELI LILLY AND COELI LILLY AND CO

ELI LILLY AND CO

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

LLY chart


Full chart

Key facts today

Eli Lilly announced that its Phase 2 clinical trial for muvalaplin, aimed at inhibiting lipoprotein(a) formation, met its primary endpoint, showing reductions in Lp(a) levels compared to placebo.
Eli Lilly's Zepbound is primarily covered by US government health plans, with Medicaid being the largest source of coverage for new weight-loss drugs, providing access to 31.6 million Americans.
Analyze the impactAnalyze the impact

LLY upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪629.35 B‬ CHF
Dividend yield (indicated)
0.70%
Price to earnings Ratio (TTM)
82.441
Basic EPS (TTM)
7.768 CHF
Net income (FY)
‪4.41 B‬ CHF
Revenue (FY)
‪28.73 B‬ CHF
Shares float
‪850.67 M‬
Beta (1Y)
1.05

Employees


Employees (FY)
‪43 K‬
Change (1Y)
‪+4 K‬ +10.26%
Revenue / Employee (1Y)
‪793.58 K‬ CHF
Net income / Employee (1Y)
‪121.87 K‬ CHF

About Eli Lilly and Company


Sector
Health Technology
CEO
David A. Ricks
Headquarters
Indianapolis
Website
lilly.com
Founded
1876
FIGI
BBG006M6Y8R4
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

LLY news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

LLY highest yielding bonds


US532457AM0
ELI LILLY 2025
Yield to maturity
6.08%
Maturity date
Jun 1, 2025
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.42%
Maturity date
Aug 14, 2064
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
5.39%
Maturity date
Jun 15, 2044
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.38%
Maturity date
Feb 9, 2064
US532457BS6
ELI LILLY 19/39
Yield to maturity
5.35%
Maturity date
Mar 15, 2039
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.33%
Maturity date
Feb 27, 2063
LLY5871803
Eli Lilly and Company 5.05% 14-AUG-2054
Yield to maturity
5.33%
Maturity date
Aug 14, 2054
LLY5750031
Eli Lilly and Company 5.0% 09-FEB-2054
Yield to maturity
5.33%
Maturity date
Feb 9, 2054
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053
Yield to maturity
5.29%
Maturity date
Feb 27, 2053
US532457BT4
ELI LILLY 19/49
Yield to maturity
5.26%
Maturity date
Mar 15, 2049
US532457BU1
ELI LILLY 19/59
Yield to maturity
5.23%
Maturity date
Mar 15, 2059

Explore more bonds 

Sparks


Curated watchlists where LLY is featured.

See all sparks 

Frequently Asked Questions


The current price of LLY is 636.194 CHF — it has decreased by −4.98% in the past 24 hours. Watch ELI LILLY AND CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ELI LILLY AND CO stocks are traded under the ticker LLY.
LLY stock has fallen by −13.44% compared to the previous week, the month change is a −19.42% fall, over the last year ELI LILLY AND CO has showed a 20.79% increase.
We've gathered analysts' opinions on ELI LILLY AND CO future price: according to them, LLY price has a max estimate of 1,110.55 CHF and a min estimate of 621.91 CHF. Watch LLY chart and read a more detailed ELI LILLY AND CO stock forecast: see what analysts think of ELI LILLY AND CO and suggest that you do with its stocks.
LLY reached its all-time high on Jul 15, 2024 with the price of 861.403 CHF, and its all-time low was 212.599 CHF and was reached on Jul 19, 2021. View more price dynamics on LLY chart.
See other stocks reaching their highest and lowest prices.
LLY stock is 5.24% volatile and has beta coefficient of 1.05. Track ELI LILLY AND CO stock price on the chart and check out the list of the most volatile stocks — is ELI LILLY AND CO there?
Today ELI LILLY AND CO has the market capitalization of ‪625.77 B‬, it has increased by 6.07% over the last week.
Yes, you can track ELI LILLY AND CO financials in yearly and quarterly reports right on TradingView.
ELI LILLY AND CO is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
LLY earnings for the last quarter are 1.00 CHF per share, whereas the estimation was 1.20 CHF resulting in a −16.97% surprise. The estimated earnings for the next quarter are 4.83 CHF per share. See more details about ELI LILLY AND CO earnings.
ELI LILLY AND CO revenue for the last quarter amounts to ‪9.69 B‬ CHF, despite the estimated figure of ‪10.25 B‬ CHF. In the next quarter, revenue is expected to reach ‪12.37 B‬ CHF.
LLY net income for the last quarter is ‪822.26 M‬ CHF, while the quarter before that showed ‪2.67 B‬ CHF of net income which accounts for −69.17% change. Track more ELI LILLY AND CO financial stats to get the full picture.
Yes, LLY dividends are paid quarterly. The last dividend per share was 1.15 CHF. As of today, Dividend Yield (TTM)% is 0.67%. Tracking ELI LILLY AND CO dividends might help you take more informed decisions.
ELI LILLY AND CO dividend yield was 0.78% in 2023, and payout ratio reached 77.91%. The year before the numbers were 1.07% and 56.79% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 19, 2024, the company has ‪43.00 K‬ employees. See our rating of the largest employees — is ELI LILLY AND CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELI LILLY AND CO EBITDA is ‪13.65 B‬ CHF, and current EBITDA margin is 34.73%. See more stats in ELI LILLY AND CO financial statements.
Like other stocks, LLY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELI LILLY AND CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ELI LILLY AND CO technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ELI LILLY AND CO stock shows the neutral signal. See more of ELI LILLY AND CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.